| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $264.2M | — | +23.1% |
| Cost of Revenue | $37.5M | — | +49.7% |
| Gross Profit | $226.7M | — | +19.6% |
| R&D Expense | $71.5M | — | +9.3% |
| SG&A Expense | $51.6M | — | +1.0% |
| Operating Income | -$15.7M | — | +54.5% |
| Pre-tax Income | -$3.5M | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $335.4M | +46.1% | +31.2% |
| Accounts Receivable | $200.3M | -34.2% | -0.5% |
| Current Assets | $1.64B | -1.0% | +18.7% |
| Total Assets | $1.71B | -1.0% | +18.3% |
| Current Liabilities | $643.0M | -1.4% | +15.6% |
| Total Liabilities |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $149.2M | — | +40.4% |
| Capital Expenditures | $2.4M | — | +162.4% |
| Investing Cash Flow | $4.2M | — | +105.1% |
| Financing Cash Flow | -$47.8M | — | -1537.3% |
| Free Cash Flow | $146.8M | — | +39.3% |
| +89.5% |
| Income Tax | $2.0M | — | -20.0% |
| Net Income | -$5.0M | — | +86.1% |
| EPS (Basic) | -$0.03 | — | +86.4% |
| EPS (Diluted) | -$0.03 | — | +86.4% |
| $674.1M |
| -1.8% |
| +14.4% |
| Stockholders' Equity | $985.2M | -0.6% | +21.9% |